Publicacións (40) Publicacións de Gema Barbeito Castiñeiras

2024

  1. Dispersal history of SARS-CoV-2 in Galicia, Spain

    Journal of Medical Virology, Vol. 96, Núm. 7

  2. Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain

    Emerging Microbes and Infections

  3. Oral specimens as a tool for accurate metagenomic analysis: A pilot study

    Journal of Stomatology, Oral and Maxillofacial Surgery, Vol. 125, Núm. 5

  4. Safety and efficacy of personalised versus standard dosing of linezolid in patients with sepsis (SePkLin): a pragmatic, multicentre, randomised, controlled and superiority clinical trial protocol

    BMJ open, Vol. 14, Núm. 10, pp. e087465

2023

  1. Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract

    Journal of Infection, Vol. 87, Núm. 6, pp. 538-550

  2. Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial

    Pharmaceutics, Vol. 15, Núm. 2

  3. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    The Lancet Regional Health - Europe, Vol. 34

  4. Systematic influenza screening in cardiac intensive care units during the influenza season: A prospective study in Spain

    International Journal of Infectious Diseases, Vol. 136, pp. 37-42

2022

  1. A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity

    Environmental Research, Vol. 210

  2. Characterisation of the blood RNA host response underpinning severity in COVID-19 patients

    Scientific Reports, Vol. 12, Núm. 1

  3. Oral microbiome and systemic antineoplastics in cancer treatment: A systematic review

    Medicina oral, patologia oral y cirugia bucal, Vol. 27, Núm. 3, pp. e248-e256

  4. Risk Factors of Mortality in Hospitalized Patients With COVID-19 Applying a Machine Learning Algorithm

    Open Respiratory Archives, Vol. 4, Núm. 2

  5. The unexpected high prevalence of HBV subgenotype D4 in patients with chronic hepatitis B in Galicia, a northwestern Spanish region, reflects strong links with Latin America

    Journal of Clinical Virology, Vol. 153

2021

  1. Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection

    Pharmaceutics, Vol. 13, Núm. 3

  2. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  3. Non-Tuberculous Mycobacteria: Beyond the Magic Mountain

    Archivos de Bronconeumologia

  4. Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis

    Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1631-1637

  5. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  6. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations

    British Journal of Clinical Pharmacology, Vol. 86, Núm. 8, pp. 1661-1666